120 related articles for article (PubMed ID: 22848244)
1. A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER(+), PR(+), ER(+)PR(+) and HER2(-) expression in women.
Zhang M; Guo LL; Cheng Z; Liu RY; Lu Y; Qian Q; Lei Z; Zhang HT
Oncol Lett; 2011 Jul; 2(4):653-658. PubMed ID: 22848244
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
[TBL] [Abstract][Full Text] [Related]
3. [Correlations of polymorphisms of TGFB1 and TGFBR2 genes to genetic susceptibility to gastric cancer].
Zhou Y; Jin GF; Jiang GJ; Wang HM; Tan YF; Ding WL; Wang LN; Chen WS; Ke Q; Shen J; Xu YC; Shen HB
Ai Zheng; 2007 Jun; 26(6):581-5. PubMed ID: 17562261
[TBL] [Abstract][Full Text] [Related]
4. Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control study.
Xu L; Zeng Z; Chen B; Wu X; Yu J; Xue L; Tian L; Wang Y; Chen M; Sung JJ; Hu P
Oncol Lett; 2011 Mar; 2(2):371-377. PubMed ID: 22866090
[TBL] [Abstract][Full Text] [Related]
5. Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population.
Jin G; Wang L; Chen W; Hu Z; Zhou Y; Tan Y; Wang J; Hua Z; Ding W; Shen J; Zhang Z; Wang X; Xu Y; Shen H
Int J Cancer; 2007 Mar; 120(6):1330-5. PubMed ID: 17187359
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
7. Association between the TGFBR2 G-875A polymorphism and cancer risk: evidence from a meta-analysis.
Huang YS; Zhong Y; Yu L; Wang L
Asian Pac J Cancer Prev; 2014; 15(20):8705-8. PubMed ID: 25374194
[TBL] [Abstract][Full Text] [Related]
8. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
9. Lifetime moderate-to-vigorous physical activity and ER/PR/HER-defined post-menopausal breast cancer risk.
Shi J; Kobayashi LC; Grundy A; Richardson H; SenGupta SK; Lohrisch CA; Spinelli JJ; Aronson KJ
Breast Cancer Res Treat; 2017 Aug; 165(1):201-213. PubMed ID: 28589367
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
11. Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer.
Liu XY; Ma D; Xu XE; Jin X; Yu KD; Jiang YZ; Shao ZM
Theranostics; 2018; 8(22):6386-6399. PubMed ID: 30613307
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Mortality among Asian-American Women in California: Variation according to Ethnicity and Tumor Subtype.
Parise C; Caggiano V
J Breast Cancer; 2016 Jun; 19(2):112-21. PubMed ID: 27382386
[TBL] [Abstract][Full Text] [Related]
13. SERUM THYROTROPIN CONCENTRATIONS ARE NOT PREDICTIVE OF AGGRESSIVE BREAST CANCER BIOLOGY IN EUTHYROID INDIVIDUALS.
Villa NM; Li N; Yeh MW; Hurvitz SA; Dawson NA; Leung AM
Endocr Pract; 2015 Sep; 21(9):1040-5. PubMed ID: 26121443
[TBL] [Abstract][Full Text] [Related]
14. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
[TBL] [Abstract][Full Text] [Related]
15. CORRELATION BETWEEN CLINICAL PATHOLOGY OF LUMINAL B BREAST CANCER AND DETERMINATION OF ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND HER2 EXPRESSION COMBINED WITH NUCLEAR MORPHOLOGY.
Yin D; Wang YL; Wang YF; Yang L; Zhang L; Tang C; Xie W; Ma Y
J Biol Regul Homeost Agents; 2015; 29(3):579-87. PubMed ID: 26403396
[TBL] [Abstract][Full Text] [Related]
16. Involvement of INF-γ functional single nucleotide polymorphism +874 T/A (rs2430561) in breast cancer risk.
Al-Rashidi HE; Refaat S; Ahmed E; Hussein DT; Eltantawy FM; Hamed S
Saudi J Biol Sci; 2021 Nov; 28(11):6289-6296. PubMed ID: 34759748
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.
Vitiello GAF; Guembarovski RL; Hirata BKB; Amarante MK; de Oliveira CEC; de Oliveira KB; Cebinelli GCM; Guembarovski AL; Campos CZ; Watanabe MAE
J Cancer Res Clin Oncol; 2018 Apr; 144(4):645-655. PubMed ID: 29362917
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China.
Xing P; Li J; Jin F
Med Oncol; 2010 Sep; 27(3):926-31. PubMed ID: 19771534
[TBL] [Abstract][Full Text] [Related]
19. Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.
Berghuis AMS; van Deurzen CHM; Koffijberg H; Terstappen LWMM; Sleijfer S; IJzerman MJ
Breast Cancer Res Treat; 2019 Jun; 175(2):451-458. PubMed ID: 30756285
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]